Evidence map›Paper›PMID 41714532›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026

Stage-specific interactions among PLM, RBD, and OSAHS in parkinson's disease and MSA.

Zhiying Zhang, Mengyun Li, Yuzhou Wang, Xiaodi Li, Jiangpei Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhiying Zhang *Department of Neurology, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Mengyun Li *Department of Neurorehabilitation, Guangdong 999 Brain Hospital, Guangzhou, China.
Yuzhou Wang *Department of Neurology, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Xiaodi LiDepartment of Neurology, Guangdong 999 Brain Hospital, Guangzhou, China. lixiaodi1981@163.com.ORCID http://orcid.org/0000-0001-8655-719X
Jiangpei ZhaoDepartment of Neurology, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. zhaojp3@mail.sysu.edu.cn.

Funding

Guangzhou Municipal Science and Technology Project 202102080335National Natural Science Foundation of China 81901396
6 · The paper itself

Abstract

backgroundSleep disturbances in synucleinopathies often manifest as periodic limb movements (PLM), REM sleep behavior disorder (RBD), and obstructive sleep apnea–hypopnea syndrome (OSAHS), yet their interplay remains unclear. We explored prevalence, severity, and stage-specific interactions in multiple system atrophy (MSA) and Parkinson's disease (PD).

methodsThirty‐four MSA and 264 PD patients underwent overnight polysomnography (56 parameters) and completed an institution-specific nocturnal behavior questionnaire comprising 16 binary items, used to screen sleep-related complaints and nocturnal behaviors for correlation with PSG findings. Univariate analyses and quantile regression—selected to accommodate skewed distributions and to uncover stage‐ and severity‐specific associations across the full range of AHI, RWA, and PLM values—probed sleep stage–dependent relationships among respiratory indices, chin/submental EMG activity, and limb movements.

resultsMSA exhibited more severe disturbances than PD: RBD prevalence 47.1% vs 17.8% (p < 0.001), OSAHS prevalence 47.1% vs 30.7% (p = 0.055), RWA prevalence 11.8% vs 2.3% (p = 0.006), PLM prevalence 61.8% vs 25.0% (p < 0.001). Median PLM count and REM‐stage EMG activity were higher in MSA (139 vs 11.5 movements; 15.8% vs 1.2% RWA; both p < 0.001). Quantile regression showed respiratory events correlated with NREM PLM only at upper severity quintiles, while REM‐stage RWA predicted PLM consistently across quintiles. PD subgroup analysis revealed graded REM‐dominant phenotypes, with PD + RBD showing highest REM EMG (82.5%) and PLM burden (median 44.0).

conclusionsPLM in synucleinopathies may arise secondarily from REM disinhibition and NREM respiratory arousals. Distinct profiles in MSA versus PD reflect differential neurodegeneration and support integrated diagnostic and therapeutic approaches.

Indexed as

Multiple System AtrophyNocturnal Myoclonus SyndromeParkinson DiseaseREM Sleep Behavior DisorderSleep Apnea, ObstructiveAgedFemaleHumansMaleMiddle AgedPolysomnographyPrevalenceSeverity of Illness IndexMultiple System AtrophyObstructive Sleep Apnea–Hypopnea SyndromeParkinson's DiseasePeriodic Limb MovementsPolysomnographyREM Sleep Behavior Disorder

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.